Phase I/II study of spartalizumab (PDR001), an anti-PD1 mAb, in patients with advanced melanoma or non-small cell lung cancer
Author
Wu, H.
Sriuranpong, V.
Ponce Aix, S.
Ascierto, P. A.
Fasolo, A.
Sezer, A.
Kowalski, D. M.
Faris, J. E.
Cameron, S.
Mataraza, J.
Garrido Lopez, P.
Antona, V.
Ochoa de Olza, M.
Ozguroglu, M.
Lin, C-C.
Taylor, M.
Boni, V.
Brunsvig, P. F.
Geater, S. L.
Salvagni, S.
Metadata
Show full item recordCollections
- Bildiri [64839]